Tang and Yang (2020) reported that SNHG14 binds to miR-656-3p using dual-luciferase reporter assay in hepatocellular carcinoma (HCC). Xie et al. (2020) found that SNHG14 promoted pancreatic ductal adenocarcinoma progression by regulating E-cadherin expression by interacting with EZH2. The gene discussed is EZH2; the disease is hepatocellular carcinoma.